Neglected Disease Product Pipelines

The State of Neglected Disease Drugs, Diagnostics, and Vaccines

BVGH surveys the drug, diagnostics, and vaccines in use or in development for the management of neglected diseases. In April 2014, BVGH reviewed the drug and diagnostic pipelines for the 10 neglected tropical diseases selected as priorities by Uniting to Combat NTDS in the London Declaration. BVGH also completed a similar survey of drugs and diagnostics for tuberculosis and malaria in late 2014, as well as a survey of drugs, diagnostics, and vaccines for ebola in early 2015.

Prior work, last updated by BVGH in June 2012, examined the drug, diagnostic, and vaccine pipelines for 25 neglected diseases (including the 10 London Declaration NTDs) under the rubric of the Global Health Primer. The Global Health Primer is now maintained by Emory University.

For more information about BVGH’s Neglected Disease Product Pipelines, please contact Katy Graef at